MYCN and neoplasm: As observed with RK‐33, MYCN‐amplified tumors were most susceptible to translation repression by ceftriaxone, followed by c‐MYC‐expressing tumor cells treated with high drug doses (Figs 5K and 6F; Fig. S7C).